A Phase Ib trial with SB-414 in adults with atopic dermatitis

Trial Profile

A Phase Ib trial with SB-414 in adults with atopic dermatitis

Planning
Phase of Trial: Phase I

Latest Information Update: 25 Oct 2017

At a glance

  • Drugs SB 414 (Primary)
  • Indications Atopic dermatitis
  • Focus Adverse reactions
  • Most Recent Events

    • 25 Oct 2017 New trial record
    • 18 Oct 2017 According to a Novan media release, company plans initiate this trial to before year end with top line results expected in the third quarter of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top